Amerge Oral Tablet 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Amerge: Oral tablet (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_3320.JPG
Amerge 1mg Tab
GlaxoSmithKline Group of Companies
Pill Identification: GX CE3 

What is this Medicine?

NARATRIPTAN (NAR a trip tan) is used to treat migraines with or without aura. An aura is a strange feeling or visual disturbance that warns you of an attack. It is not used to prevent migraines.

CVS Pharmacy Patient Statistics for Amerge: Oral tablet(1mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Amerge 1mg Tablet

NDC: 001730561
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Migraine

Sometimes used for but not FDA approved for the following conditions:
Menstrual Migraine Prophylaxis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Amerge 1mg Tablet
Drug Image file DrugItem_3320.JPG
GlaxoSmithKline Group of Companies
Pill Identification: GX CE3 
Shape: D-shaped/U-shaped
Color: white

Reported Side Effects for Amerge 1mg Tablet

Deafness Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Increased Blood Fats Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Hostility Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Dry Skin Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Dry Eyes Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Hyperesthesia Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Urinary Urgency Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Uncontrolled Urination Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Hypoesthesia Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Decreased Thinking Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Infected Salivary Gland Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Decreased Sexual Desire Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Protein In The Urine Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Chest Pain Or Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Elevated Hepatic Enzymes Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Breathing Difficulties Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Fluid From Breast Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Skin Redness Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Unable To Speak Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Convulsions Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Glycosuria Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Hallucinations Incidence:
<0.1%*
Severity: MODERATE
Onset: EARLY
Bruises Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Scotomata Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Throat Infection Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Slow Heart Beat Incidence:
<0.1%*
Severity: SEVERE
Onset: RAPID
Bone Pain Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Hair Loss Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Acne Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Eye Pain Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Inflamed Nerve Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Bleeding Within The Eye Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Underactive Thyroid Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<0.1%*
Severity: MODERATE
Onset: RAPID
Stomach Ulcer Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
High Cholesterol Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Hemorrhoids Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Inflamed Hair Follicles Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Photosensitivity Incidence:
<0.1%*
Severity: MILD
Onset: DELAYED
Throat Inflammation Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Excessive Thirst Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Excessive Sweating Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Muscle Pain Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
0.1-1.0%*
Severity: MILD
Onset: RAPID
Bladder Infection Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
0.1-1.0%*
Severity: MILD
Onset: RAPID
Cough Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Inceased Urination Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Chills Incidence:
0.1-1.0%*
Severity: MILD
Onset: RAPID
Nervousness Incidence:
0.1-1.0%*
Severity: MILD
Onset: DELAYED
Diuresis Incidence:
0.1-1.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Light Sensitivity Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Sinus Infection Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0-5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Amerge 1mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Tobacco and Amerge 1mg Tablet(Naratriptan Hydrochloride)
Tobacco and Naratriptan Hydrochloride(Naratriptan Hydrochloride)
Tobacco smoking results in a speedier removal of naratriptan from the body. However, it is not expected that this interaction will affect naratriptan's efficacy in treating migraines. Tobacco smoking can be a risk factor for heart and vascular disease; check with your doctor regarding quitting smoking if you are a frequent migraine sufferer.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Amerge

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5